We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWorsley Inv Ltd Regulatory News (WINV)

Share Price Information for Worsley Inv Ltd (WINV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.80
Bid: 23.00
Ask: 26.80
Change: 0.00 (0.00%)
Spread: 3.80 (16.522%)
Open: 25.80
High: 0.00
Low: 0.00
Prev. Close: 25.80
WINV Live PriceLast checked at -
Worsley Investors is an Investment Trust

To provide Shareholders with an attractive level of absolute long-term return, principally through the capital appreciation and exit of undervalued British quoted securities of smaller companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of Initial Issue

17 Mar 2020 07:00

RNS Number : 3695G
Worsley Investors Limited
17 March 2020
 

This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States, any Member State of the European Economic Area (other than the Republic of Ireland), Australia, Canada, Japan or South Africa or any jurisdiction where to do so might constitute a violation of local securities laws or regulations.

17 March 2020

 

 Worsley Investors Limited 

 ("Worsley" or "the Company")

Results of Initial Issue

The Directors of the Company are pleased to announce that the Company has received applications from Relevant Persons (as defined in the Important Notice section below) for a total of 250,000 New Ordinary Shares under the Initial Issue at the price of 30 pence per share.

As a result of the applications under the Initial Issue, Blake Nixon's application for New Ordinary Shares under the Open Offer is modestly increased by 107,142 New Ordinary Shares so that his previously accepted application and a proportion of the Over-allotted Share Amount (as defined in the Prospectus) remains just under 30 per cent. of the New Ordinary Shares issued under the Offer.

Accordingly, the Company has received valid acceptances and excess applications from Qualifying Shareholders under the Open Offer and the Initial Issue (together the "Offer") for a total of 12,982,488 New Ordinary Shares and has raised gross proceeds of £3.9 million.

Applications have been made to the Financial Conduct Authority and the London Stock Exchange for all of the New Ordinary Shares to be issued pursuant to the Offer to be admitted to the Premium Listing segment of the Official List and to trading on the London Stock Exchange's main market for listed securities. It is expected that Admission will become effective and dealings in the New Ordinary Shares will commence at 8.00 a.m. on 18 March 2020.

Directors' participation

The following Directors of the Company participated in the Offer:

Name of Director

Number of shares subscribed for in the Offer

Ordinary Shares to be held following Admission of New Ordinary Shares

Total interest in issued share capital following Admission of New Ordinary Shares

Blake Nixon

3,894,746

10,083,126

29.88%

William Scott

250,000

400,000

1.19%

 

As stated in the Prospectus, Mr Nixon has subscribed for just under 30 per cent. of the total New Ordinary Shares issued under the Offer.

Total voting rights

Following Admission, the Company's issued share capital will comprise 33,740,929 Ordinary Shares and this is the total number of Ordinary Shares with voting rights in the Company. This figure (33,740,929) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules. The Company does not currently hold any shares in treasury.

All capitalised terms in this announcement have the meaning given to them in the Prospectus, unless otherwise defined herein.

Enquiries:

For further information, please contact:

Worsley Associates LLP (Investment Advisor)

Blake NixonTel: +44 (0) 203 873 2288

Shore Capital (Financial Adviser and Broker)

Robert Finlay / Anita Ghanekar / Hugo MasefieldTel: +44 (0) 20 74080 4050

Praxis Fund Services Limited (Administrator and Secretary)Matt Falla / Katrina Rowe

Tel: +44 (0) 1481 73760

LEI: 213800AF85VEZMDMF931

Important Notice

Except where the context requires otherwise, until the expiry of the transition period agreed between the United Kingdom and the European Union as part of the terms of the United Kingdom's exit from the European Union, a reference to the European Union or the European Economic Area is a reference to the members of the European Union or European Economic Area from time to time, as applicable together with the United Kingdom.

This announcement does not contain or constitute an offer of, or the solicitation of an offer to buy, or subscribe for, the New Ordinary Shares or any other securities to any person in Australia, Canada, Japan or South Africa, or the United States or in any jurisdiction to whom or in which such offer or solicitation is unlawful. Subject to certain exceptions, the securities referred to herein may not be offered or sold in Australia, Canada, Japan or South Africa or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada, Japan or South Africa. The offer and sale of the securities referred to herein has not been and will not be registered under the US Securities Act or under the applicable securities laws of Australia, Canada, Japan or South Africa. The availability of the Open Offer to persons not resident in the United Kingdom may be affected by the laws of the relevant jurisdictions. Such persons should inform themselves about and observe any application requirements.

The New Shares have not been and will not be registered under the US Securities Act or under the securities laws of any state or other jurisdiction of the United States or under any securities laws of Australia, Canada, Japan or South Africa or any other jurisdiction where to do so would be unlawful and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States, or within any of Australia, Canada, Japan or South Africa or any other jurisdiction where to do so would be unlawful. There will be no public offer of the New Ordinary Shares in the United States.

This communication is only addressed to, and directed at, persons in member states of the European Economic Area (other than the United Kingdom) who are "qualified investors" within the meaning of Article 2(e) of the Prospectus Regulation ("Qualified Investors"). For the purposes of this provision, the expression "Prospectus Regulation" means Regulation (EU) 2017/1129. In addition, in the United Kingdom, this communication is being distributed only to, and is directed only at, Qualified Investors: (i) who have professional experience in matters relating to investments who fall within the definition of "investment professional" in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) who are high net worth companies, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2) of the Order, and (iii) other persons to whom it may otherwise lawfully be communicated (all such persons together being referred to as "Relevant Persons"). Any investment or investment activity to which this communication relates is available only to and will only be engaged in with such persons. This communication must not be acted on or relied on in any member state of the European Economic Area other than the United Kingdom and Republic of Ireland, by persons who are not Qualified Investors.

The distribution of this announcement and the offering of the New Ordinary Shares in jurisdictions other than the United Kingdom and Republic of Ireland may be restricted by law. No action has been taken by the Company or Shore Capital and Corporate Limited that would permit an offering of such shares or possession or distribution of this announcement or any other offering or publicity material relating to such shares in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required by the Company and Shore Capital and Corporate Limited to inform themselves about, and to observe, any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement may not be used in making any investment decision. This announcement does not contain sufficient information to support an investment decision and investors should ensure that they obtain all available relevant information before making any investment. This announcement does not constitute and may not be construed as an offer to sell, or an invitation to purchase or otherwise acquire, investments of any description, nor as a recommendation regarding the possible offering or the provision of investment advice by any party. No information in this announcement should be construed as providing financial, investment or other professional advice and each prospective investor should consult its own legal, business, tax and other advisers in evaluating the investment opportunity. No reliance may be placed for any purposes whatsoever on this announcement or its completeness. Nothing in this announcement constitutes investment advice and any recommendations that may be contained herein have not been based upon a consideration of the investment objectives, financial situation or particular needs of any specific recipient.

Potential investors should be aware that any investment in the Company is speculative, involves a high degree of risk, and could result in the loss of all or substantially all of their investment. Results can be positively or negatively affected by market conditions beyond the control of the Company or any other person. The returns set out in this document are targets only. There is no guarantee that any returns set out in this document can be achieved or can be continued if achieved, nor that the Company will make any distributions whatsoever. There may be other additional risks, uncertainties and factors that could cause the returns generated by the Company to be materially lower than the returns set out in this announcement.

This announcement has been issued by and is the sole responsibility of the Company. No representation or warranty, express or implied is, or will be made as to, or in relation to, and no responsibility or liability is, or will be, accepted by Shore Capital and Corporate Limited or by any of their affiliates or agents as to, or in relation to, the accuracy or completeness of this announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefore is expressly disclaimed.

Shore Capital and Corporate Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, has been appointed to act as sponsor and financial adviser to the Company in connection with the Open Offer and Initial Issue. Shore Capital and Corporate Limited is authorised and regulated in the United Kingdom by the Financial Conduct Authority, Persons viewing this announcement should note that, in connection with the Open Offer and Initial Issue, Shore Capital and Corporate Limited is acting exclusively for the Company and no one else. Apart from the responsibilities and liabilities, if any, which may be imposed on Shore Capital and Corporate Limited. by FSMA, Shore Capital and Corporate Limited will not be responsible to anyone other than the Company for providing the protections afforded to clients of Shore Capital and Corporate Limited or for advising any other person on the transactions and arrangements described in this announcement. No representation or warranty, express or implied, is made by Shore Capital and Corporate Limited. as to any of the contents of this announcement for which the Company and the Directors are solely responsible. Shore Capital and Corporate Limited. has not authorised the contents of, or any part of, this announcement and (without limiting the statutory rights of any person to whom this announcement is issued) no liability whatsoever is accepted by Shore Capital and Corporate Limited for the accuracy of any information or opinions contained in this announcement or for the omission of any material information, for which the Company and the Directors are solely responsible. Accordingly, Shore Capital and Corporate Limited disclaim (to the extent permitted by law) any liability which they might otherwise have in respect of any of the information or opinions contained in this announcement, whether arising in tort, contract or otherwise.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROIFQLLFBXLZBBB
Date   Source Headline
27th Mar 202410:54 amRNSDirector/PDMR Shareholding
1st Mar 20249:03 amRNSNet Asset Value(s)
21st Dec 20236:11 pmRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSHalf-year Report
29th Nov 20237:00 amRNSNet Asset Value(s)
25th Sep 202311:20 amRNSDirector/PDMR Shareholding
13th Sep 20233:04 pmRNSResult of AGM
30th Aug 20237:00 amRNSNet Asset Value(s)
21st Aug 202311:36 amRNSNotice of AGM
5th Jul 20237:00 amRNSAnnual Report for the period ended 31 March 2023
30th May 202310:04 amRNSNet Asset Value(s)
1st Mar 20237:00 amRNSNet Asset Value(s)
13th Feb 20239:00 amRNSChange of Registered Office
19th Jan 202312:36 pmRNSDirector/PDMR Shareholding
10th Jan 20231:09 pmRNSHolding(s) in Company
15th Dec 20227:00 amRNSHalf-year Report
18th Nov 20227:00 amRNSNet Asset Value(s)
10th Nov 20224:40 pmRNSSecond Price Monitoring Extn
10th Nov 20224:35 pmRNSPrice Monitoring Extension
9th Nov 20227:00 amRNSHolding(s) in Company
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:36 pmRNSPrice Monitoring Extension
4th Oct 20224:40 pmRNSSecond Price Monitoring Extn
4th Oct 20224:36 pmRNSPrice Monitoring Extension
22nd Sep 20224:44 pmRNSResult of AGM
12th Sep 202212:24 pmRNSDirector/PDMR Shareholding
9th Sep 20224:04 pmRNSHolding(s) in Company
2nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
2nd Sep 20224:36 pmRNSPrice Monitoring Extension
30th Aug 20227:00 amRNSNet Asset Value(s)
23rd Aug 20224:15 pmRNSNotice of AGM
10th Aug 202211:51 amRNSDirector/PDMR Shareholding
8th Aug 202211:48 amRNSDirector/PDMR Shareholding
18th Jul 20227:00 amRNSAnnual Report for the period ended 31 March 2022
7th Jun 20226:01 pmRNSNet Asset Value(s)
19th May 20223:28 pmRNSDirector/PDMR Shareholding
12th May 20222:51 pmRNSDirector/PDMR Shareholding
2nd Mar 20225:06 pmRNSNet Asset Value(s)
16th Dec 20217:00 amRNSHalf-year Report
7th Dec 20215:45 pmRNSAcquisition of Praxis Fund Services by Sanne Group
5th Nov 20211:22 pmRNSNet Asset Value(s)
17th Aug 20217:00 amRNSNet Asset Value(s)
21st Jul 20217:00 amRNSNotice of AGM
25th Jun 20217:00 amRNSAnnual Report for the period ended 31 March 2021
12th May 20217:00 amRNSNet Asset Value(s)
26th Apr 20217:00 amRNSCurno cinema update
17th Mar 20217:00 amRNSHalf-year Report
9th Feb 20217:00 amRNSNet Asset Value(s)
8th Dec 20203:28 pmRNSResult of AGM
4th Nov 20207:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.